{"brief_title": "Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy", "brief_summary": "The purpose of this study is to determine the effectiveness of different doses of epoetin alfa for treating anemia in patients who have cancer; or patients who no longer have any signs of cancer, but remain anemic as a result of their treatment. These patients should not be currently receiving chemotherapy or radiotherapy. A subject's participation in the study will last approximately 6 months. Subjects will receive weekly doses of epoetin alfa or placebo. Their hemoglobin will be tested every week.", "condition": "Anemia", "intervention_type": "Drug", "intervention_name": "epoetin alfa", "criteria": "Inclusion Criteria: - Body weight >/=99 lbs - ECOG 0-2 - Anemia results from cancer, chemotherapy, radiotherapy or an association with hormonal therapy or immunotherapy - Screening hemoglobin level of </=11.0 g/dL for men or </=10.0 for women", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00083486.xml"}